FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386960009: Tranexamic acid (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461138013 Tranexamic acid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481074012 Tranexamic acid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56971000195116 acido tranexamico it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
44891000188110 acide tranéxamique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
847101000172115 acide tranexamique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
72051000195111 Tranexamsäure de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tranexamic acid (substance) Is a Hemostatic agent (substance) true Inferred relationship Some
Tranexamic acid (substance) Is a classe d'allergènes false Inferred relationship Some
Tranexamic acid (substance) Is a allergène médicamenteux false Inferred relationship Some
Tranexamic acid (substance) Is a Carboxylic acid true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tranexamic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid adverse reaction Causative agent (attribute) True Tranexamic acid (substance) Inferred relationship Some 1
Allergy to tranexamic acid (finding) Causative agent (attribute) False Tranexamic acid (substance) Inferred relationship Some
Tranexamic acid 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some
acide tranexamique 100 mg/mL, ampoule de solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some
Tranexamic acid 100mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some
Tranexamic acid 100mg/mL intravenous solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some
Tranexamic acid 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some
Allergy to tranexamic acid (finding) Causative agent (attribute) True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 650 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 100mg/mL conventional release solution for injection 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tranexamic acid (substance) Inferred relationship Some
Tranexamic acid 650 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tranexamic acid (substance) Inferred relationship Some 1
Product containing precisely tranexamic acid 500 milligram/5 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Tranexamic acid (substance) Inferred relationship Some 1
Product containing precisely tranexamic acid 500 milligram/5 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Product containing only tranexamic acid in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 100 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tranexamic acid (substance) Inferred relationship Some 1
Tranexamic acid 100 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tranexamic acid (substance) Inferred relationship Some 1
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tranexamic acid (substance) Inferred relationship Some 1
Etamsylate 250 mg and tranexamic acid 250 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Tranexamic acid (substance) Inferred relationship Some 1
Etamsylate- and tranexamic acid-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Product containing only etamsylate and tranexamic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Etamsylate- and tranexamic acid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1
Etamsylate and tranexamic acid only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tranexamic acid (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start